Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Sequential Intravesical Valrubicin and Docetaxel for the Salvage Treatment of Non-Muscle-Invasive Bladder Cancer.

Ian M McElree,Vignesh T Packiam,Ryan L Steinberg,Sarah L Mott,Paul T Gellhaus,Kenneth G Nepple,Michael A O'Donnell

The Journal of urology（2022）

Cited 2|Views11
No score
Abstract
In a heavily pretreated population, our results suggest valrubicin and docetaxel is an effective rescue treatment for patients with recurrent non-muscle-invasive bladder cancer. Further prospective evaluation is needed.
More
Translated text
Key words
docetaxel,urinary bladder neoplasms,valrubicin
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined